Subscribe


PD breaking news – ACCC Lipitor case dismissed

Pfizer’s market power not “substantial” at time of Lipitor offers. 

The Federal Court has dismissed the Australian Competition and Consumer Commission’s (ACCC) anti-competitive conduct case against Pfizer Australia today.

The ACCC allegations related to offers made to pharmacies in early 2012 for the supply of Lipitor and Pfizer’s generic atorvastatin product, with the organisation alleging Pfizer had a substantial degree of market power in the atorvastatin market and was proscribed from using that power to prevent competitive conduct (PD 08 Oct 14).

Justice Flick found that while Pfizer had taken advantage of its market power by engaging in the alleged conduct, this market power was no longer “substantial” at the time the offers were made in January 2012, the ACCC said.

The Justice also found the ACCC had not established that Pfizer had pursued its conduct to deter competitors from engaging in competitive conduct or for the purpose of substantially lessening competition, the organisation said.

Previously, the ACCC said it would seek in excess of $10m for each alleged contravention.

Chairman Rod Sims said the organisation would “carefully consider” the judgement.

“The ACCC brought this case because it raised important public interest issues regarding the conduct of a patent holder nearing the expiry of that patent and what constitutes permissible competitive conduct.”

See tomorrow’s Pharmacy Daily for more information.

This Pharmacy Daily breaking news brought to you by Pharmacy Daily.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 25 Feb 15

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

22 Jan

Weekly Comment 22 Jan 18 - WELCOME to PD's weekly comment feature. This ...


22 Jan

Dispensary Corner 22 Jan 18 - MEDICINAL marijuana is the subject of several ...


22 Jan

FDA pings Delta Labs - THE US Food and Drug Administration (FDA) ...


22 Jan

S3 ad clarification - THE Therapeutic Goods Administration has stressed that ...


22 Jan

Opioid consultation - OPTIONS for a regulatory response to opioid ...


22 Jan

Metformin recall - APOTEX is recallilng one patch of APO-Metformin ...


22 Jan

API warns of slow sales - AUSTRALIAN Pharmaceutical Industries this morning alerted investors ...


22 Jan

Concern over CM ad changes - THE Federal government has been accused of ...


19 Jan

Dispensary Corner 19 Jan 18 - IT MAKES perfect sense for the operation ...


19 Jan

PBA data released - THE Pharmacy Board of Australia has released ...


19 Jan

‘Out of pocket pain’ - THE Consumers Health Forum (CHF) has announced ...


19 Jan

Cannabis PBS listing? - VICTORIAN Health Minister Jill Hennessy has confirmed ...


19 Jan

Industrial hemp meet - THE Australian Industrial Hemp Conference is calling ...


19 Jan

S3 advertising permitted - THE Therapeutic Goods Administration has confirmed that ...


19 Jan

Codeine story ‘misleading’ - WHILE the rescheduling of products containing codeine ...


18 Jan

Travel Specials 18 Jan 18 - VIEW & Verandah Sale by Holland America ...


18 Jan

Dispensary Corner 18 Jan 18 - NEWLYWEDS from Northern Ireland have wasted no ...


18 Jan

CW float speculation - THE owners of Chemist Warehouse may be ...


18 Jan

Life-Long Learning - THE Australian Pharmacy Council has announced the ...


18 Jan

FIP Glasgow regos - REGISTRATIONS have opened for the 78th International ...



Show Pharmacy Daily items by month: